Startup company launched – Vega BioImaging
Retour aux nouvelles
Re-inventing cytopathology Enabling precision medicine in cancer through precise cytopathology diagnostic.
After more than 10 years of research and development in the field of biomedical nanoplasmonic imaging and detection, carried out at the Polytechnique Montreal (Prof. M. Meunier) and funded by projects CHRP, NSERC, Oncotech, allowed to prove the basic scientific principles of the technology.
Prof. Michel Meunier
Cécile Darviot. M.Sc.
Sergiy Patskovsky, Ph.D.
To learn more about the company, Vega Bioimaging